cobas Mass Spec soltution

Enter a new dimension in mass spectrometry

Step away from complex and manual mass spectrometry workflows and experience the simplicity and convenience of a streamlined end-to-end solution.

Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases

 

About Roche Diagnostics

Featured products and solutions

Designed to help improve workflows and change healthcare in favor of cost efficiency and better patient care, the cobas pulse system is your gateway to the future of digital health.
Take integration to the next power with cobas® infinity IT solutions. It was designed from the drawing board for people to work to their full potential. With cobas® infinity IT solutions powering your lab, performance that was once not possible, is now a reality.

Our managed laboratory service: transparent, tailored, trusted

Boost your efficiency with fast analytical units, intelligent sample routing, and short assay incubation times. 
Workflow flexibility meets high-capacity with the VENTANA DP 600 digital pathology slide scanner featuring a slide tray-based system and built-in calibrations.

Learn how the SARS-CoV-2 Rapid Antigen Test works

 

Immunoassay for the quantitative determination of antibodies to the SARS-CoV-2 spike protein
...
    ...

    Doing now what patients need next.
     

    At Roche Diagnostics we believe time is precious and we are dedicated to providing diagnostic tests and services that give people more time with their loved ones.

    We are proud to be the UK’s leading provider of in vitro diagnostics tests1 and in 2020 more than 820 million Roche diagnostic tests were used by clinicians across the UK to confirm, rule out or manage health conditions including cancer, heart disease, diabetes, COVID-19, hepatitis, human papillomavirus (HPV) and many others2.

    Related links

    Researcher face with glasses smiling

    Roche Research Solutions

    Advancing research and empowering discoveries

    Roche research technologies and solutions support researchers from enquiry to impact.
Roche provides researchers with leading innovations, instruments and reagents for genome sequencing, tissue staining, microarray analysis, nucleic acid purification, cell analysis and real-time qPCR.


    Working with you, we’ll streamline implementation and accelerate discovery in your lab. Roche is assisting scientists in advancing research, which may contribute to more efficient timelines for publication and practical application of their findings.

    Digital pathology screen and clinician

    Leaders in Digital Pathology

    We recently spoke with leaders in digital pathology to understand their views about how the technology can transform patient care and accelerate the adoption of personalised medicine.

    Heart failure 1st image

    Think Heart Failure 1st

    Heart failure affects nearly 1 million people in the UK, and there are an estimated 200,000 new diagnoses each year3.  One simple test could help transform lives.

     

    Cervical Cancer 2 ladies smiling

    Let's Talk Cervical Screening

    We want to open up the conversation about cervical screening - also known as a 'smear test' - providing honest views and relatable advice to help you take control of your cervical health and make an informed decision to book your appointment.

    Heart failure 1st image

    Shaping What Comes Next

    Healthcare sustainability is a growing industry concern, challenging laboratories to do more with less. We aim to provide flexible and high quality services to support you with today’s challenges, and to prepare you for the future.

    Featured Health Topics

    Partner with the pioneers for earlier, more confident clinical decision-making.

    Our commitment to women’s health: With her today. With her for life.
    ...
      ...

      References

      1. Data on file
      2. Business Intelligence Team at Roche Diagnostics
      3. Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet2018;391:572-80. doi:10.1016/ S0140-6736(17)32520-5 pmid:29174292)